China Yuchai International Limited (CYD): Price and Financial Metrics


China Yuchai International Limited (CYD)

Today's Latest Price: $16.45 USD

0.98 (-5.62%)

Updated Jan 25 4:00pm

Add CYD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 88 in Industrial - Machinery

See all "A" rated Strong Buy stocks

CYD Stock Summary

  • The price/operating cash flow metric for China Yuchai International Ltd is higher than merely 2.51% of stocks in our set with a positive cash flow.
  • CYD's price/sales ratio is 0.28; that's higher than the P/S ratio of just 5.75% of US stocks.
  • China Yuchai International Ltd's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 34.7%, greater than the shareholder yield of 93.82% of stocks in our set.
  • Stocks that are quantitatively similar to CYD, based on their financial statements, market capitalization, and price volatility, are AIN, RMTI, BHAT, FORTY, and ANY.
  • Visit CYD's SEC page to see the company's official filings. To visit the company's web site, go to www.cyilimited.com.

CYD Stock Price Chart Interactive Chart >

Price chart for CYD

CYD Price/Volume Stats

Current price $16.45 52-week high $20.49
Prev. close $17.43 52-week low $7.77
Day low $16.38 Volume 54,566
Day high $17.43 Avg. volume 39,125
50-day MA $17.18 Dividend yield 4.88%
200-day MA $15.49 Market Cap 672.15M

China Yuchai International Limited (CYD) Company Bio


China Yuchai International Limited manufactures and sells diesel and natural gas engines in the People’s Republic of China (PRC) and other countries. The company was founded in 1951 and is based in Singapore.

CYD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$16.45$156.45 798%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for China Yuchai International Ltd. To summarize, we found that China Yuchai International Ltd ranked in the 86th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 802% on a DCF basis. The most interesting components of our discounted cash flow analysis for China Yuchai International Ltd ended up being:

  • Its compound free cash flow growth rate, as measured over the past 4.04 years, is -0.07% -- higher than merely 16.49% of stocks in our DCF forecasting set.
  • The company has produced more trailing twelve month cash flow than 86.7% of its sector Industrials.
  • China Yuchai International Ltd's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 8.9% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%780%
1%789%
2%798%
3%806%
4%815%
5%824%

ARC, SGRP, KEX, PGAS, and ULBI can be thought of as valuation peers to CYD, in the sense that they are in the Industrials sector and have a similar price forecast based on DCF valuation.


CYD Latest News Stream


Event/Time News Detail
Loading, please wait...

CYD Latest Social Stream


Loading social stream, please wait...

View Full CYD Social Stream

Latest CYD News From Around the Web

Below are the latest news stories about China Yuchai International Ltd that investors may wish to consider to help them evaluate CYD as an investment opportunity.

China Yuchai: Macro And Industrial Conditions In China Provide A Solid Basis For Future Growth

Article Thesis China Yuchai International Limited (CYD) has had a strong rally since mid-March lows – the stock price increased more than 120%. In addition to the sound results in the first three quarters, the main reason for CYD’s rapid gain in valuation was due to its significant undervaluation since...

Alborada Investments on Seeking Alpha | January 21, 2021

New Strong Buy Stocks for January 12th

New Strong Buy Stocks for January 12th

Yahoo | January 12, 2021

CytoDyn to amend Phase 3 trial protocol for COVID-19 therapy

CytoDyn (CYD) has announced that the FDA has issued guidance to add an open-label extension to its Phase 3 trial (CD12) for Vyrologix™ (leronlimab-PRO 140) in severe-to-critically ill COVID-19 patients, including specific criteria for the continuation of eINDs for patients meeting the inclusion/exclusion criteria of CD12.The company expects to amend the trial...

Seeking Alpha | December 27, 2020

Is China Yuchai (CYD) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Yahoo | December 23, 2020

What Does China Yuchai International Limited's (NYSE:CYD) Share Price Indicate?

While China Yuchai International Limited ( NYSE:CYD ) might not be the most widely known stock at the moment, it...

Yahoo | December 23, 2020

Read More 'CYD' Stories Here

CYD Price Returns

1-mo N/A
3-mo -5.13%
6-mo 21.85%
1-year 33.26%
3-year -26.22%
5-year 146.42%
YTD 0.67%
2020 29.89%
2019 13.35%
2018 -42.57%
2017 73.79%
2016 38.56%

CYD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CYD Dividend History

Continue Researching CYD

Here are a few links from around the web to help you further your research on China Yuchai International Ltd's stock as an investment opportunity:

China Yuchai International Ltd (CYD) Stock Price | Nasdaq
China Yuchai International Ltd (CYD) Stock Quote, History and News - Yahoo Finance
China Yuchai International Ltd (CYD) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9227 seconds.